BIRC5 and cancer: Increasing evidence indicates that survivin (encoded by the gene BRIC5), a member of the inhibitor of apoptosis (IAP) protein family, is frequently overexpressed 25 and generally associated with a more aggressive disease progression, poor clinical outcomes and therapeutic resistance in a wide variety of human cancers 26.